Shares of Haleon PLC HLN slid 1.51% to £3.78 Thursday, on what proved to be an all-around positive trading session for the ...

A side effect the medical community is worried about is peripheral neuropathy – where there is damage to the nerves outside the brain and spinal cord. This results in pain, numbness or weakness, ...

Haleon (LSE: HLN) (NYSE: HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl ...

Expert Sales Operations.Paritosh Gupta shared the news of his new role via LinkedIn, stating, "I’m delighted to share that ...

London's IPO drought just hit a new lowand it's getting harder to ignore. AstraZeneca (NASDAQ:AZN), the UK's largest listed ...

Publicis Media has appointed Ashish Gupta as Vice President to lead the digital mandate for Haleon India. Ashish Gupta was ...

KARACHI: The Pakistan Stock Exchange (PSX) extended its record-setting streak for the fourth consecutive session ...

Topline Securities observed in its review that bulls went on a rampage as the KSE-100 index shattered records, storming past ...

Netflix has held talks for a partnership with Spotify on music shows, live concert series, big celebrity interviews and ...

Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.

LONDON - Haleon plc (LSE/NYSE:HLN) has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co. Ltd (TSKF), its over-the-counter joint venture in China ...

(Alliance News) - Haleon PLC on Friday said it completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co Ltd, its over-the-counter joint venture in China. The ...